Page last updated: 2024-08-24

3-iodobenzylguanidine and Cheyne-Stokes Respiration

3-iodobenzylguanidine has been researched along with Cheyne-Stokes Respiration in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adachi, H; Hoshizaki, H; Kan, H; Kasama, S; Kawaguti, R; Miyaishi, Y; Ohsima, S; Toyama, T; Yamashita, E	1

Trials

1 trial(s) available for 3-iodobenzylguanidine and Cheyne-Stokes Respiration

Article	Year
Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity, cardiac function, exercise capacity, and symptom in patients with chronic heart failure and Cheyne-Stokes respiration. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:6 Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Cheyne-Stokes Respiration; Chronic Disease; Exercise; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Respiration, Artificial; Sympathetic Nervous System	2017

Article

Year

Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity, cardiac function, exercise capacity, and symptom in patients with chronic heart failure and Cheyne-Stokes respiration.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:6

Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Cheyne-Stokes Respiration; Chronic Disease; Exercise; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Respiration, Artificial; Sympathetic Nervous System

2017